PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.16%
Negative net income growth while AVGO stands at 27.27%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-2.53%
Both reduce yoy D&A, with AVGO at -16.74%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-314.29%
Negative yoy deferred tax while AVGO stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
48.72%
SBC growth while AVGO is negative at -7.58%. John Neff would see competitor possibly controlling share issuance more tightly.
-341.33%
Negative yoy working capital usage while AVGO is 100.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-198.60%
Both yoy AR lines negative, with AVGO at -316.47%. Martin Whitman would suspect an overall sector lean approach or softer demand.
30.74%
Some inventory rise while AVGO is negative at -210.45%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-239.08%
Negative yoy AP while AVGO is 383.53%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-200.33%
Negative yoy usage while AVGO is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-6000.00%
Both negative yoy, with AVGO at -2375.20%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-57.51%
Negative yoy CFO while AVGO is 9.08%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
5.79%
Lower CapEx growth vs. AVGO's 18.03%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
28.82%
Some yoy expansion while AVGO is negative at -250.00%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
No Data
No Data available this quarter, please select a different quarter.
11.34%
Growth of 11.34% while AVGO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
104.07%
We have mild expansions while AVGO is negative at -31.82%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-150.00%
We cut debt repayment yoy while AVGO is 55.09%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
35.63%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-21.60%
Both yoy lines negative, with AVGO at -69.10%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.